Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena V Yakubova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2020
Reply to Krishna Prabha et alAndrey A Ivashchenko, Nikolay P Savchuk, Elena V Yakubova, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
Viruses|July 2, 2021
Effect of Aprotinin and Avifavir<sup>®</sup> Combination Therapy for Moderate COVID-19 PatientsAndrey A Ivashchenko, Valeria N Azarova, Alina N Egorova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2020
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialAndrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2020
Reply to Krishna Prabha et alAndrey A Ivashchenko, Nikolay P Savchuk, Elena V Yakubova, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
Viruses|July 2, 2021
Effect of Aprotinin and Avifavir<sup>®</sup> Combination Therapy for Moderate COVID-19 PatientsAndrey A Ivashchenko, Valeria N Azarova, Alina N Egorova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2020
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialAndrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, et al.
Pageof 1